Cediranib (C) in patients (pts) with malignant mesothelioma (MM): A phase II trial of The University of Chicago Phase II Consortium. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting ...
Toby Maher, MD, PhD, professor of clinical medicine, Keck Medicine of USC, discusses the impact of changes in lung function in patients with idiopathic pulmonary fibrosis (IPF). How does the rate of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results